Ivabradine Monotherapy for the Treatment of Congenital Junctional Ectopic Tachycardia in a Premature Neonate

Overview

Journal J Pediatr Pharmacol Ther

Specialty Pediatrics

Date 2021 May 26

PMID 34035688

Citations 1

Authors

Suzan S Asfour

Khalid A Al-Omran

Nabeel A Alodhaidan

Raneem S Asfour

Thanaa M Khalil

Mountasser M Al-Mouqdad

Affiliations

Soon will be listed here.

Abstract

Congenital junctional ectopic tachycardia is a rare and special type of supraventricular arrhythmia. Junctional ectopic tachycardia is characterized by persistently elevated heart rates that may cause an impairment in cardiac function. Junctional ectopic tachycardia is considered one of the most difficult-to-treat conditions even with a combination of antiarrhythmic medications. Ivabradine is a novel antiarrhythmic medication used to decrease the heart rate in adults with angina pectoris. We report a first case of a premature neonate with a normal heart structure who developed junctional ectopic tachycardia and was subsequently treated successfully with ivabradine.

Citing Articles

Ivabradine in treatment of symptomatic heart failure and supraventricular tachycardias in patients under six months of age.

Gomez-Ganda L, Parramon-Teixido C, Giralt-Garcia G, Fernandez-Garcia C, Ferrer-Menduina Q, Cabanas-Poy M Front Pharmacol. 2025; 16:1502375.

PMID: 40041489 PMC: 11876114. DOI: 10.3389/fphar.2025.1502375.

Ivabradine for Incessant Atrial Tachycardia in a 1-Year-Old Child After Tetralogy of Fallot Repair.

Balweel H, Sukardi R, Marwali E, Eri R, Tafriend N, Harsoyo A Case Rep Cardiol. 2025; 2025:2601345.

PMID: 39963303 PMC: 11832250. DOI: 10.1155/cric/2601345.

[Research progress in the application of ivabradine in children with cardiovascular diseases].

Jiang L Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(7):782-788.

PMID: 39014957 PMC: 11562043. DOI: 10.7499/j.issn.1008-8830.2401072.

References

Scicchitano P, Cortese F, Ricci G, Carbonara S, Moncelli M, Iacoviello M . Ivabradine, coronary artery disease, and heart failure: beyond rhythm control. Drug Des Devel Ther. 2014; 8:689-700. PMC: 4051626. DOI: 10.2147/DDDT.S60591. View

Garson Jr A, Gillette P . Junctional ectopic tachycardia in children: electrocardiography, electrophysiology and pharmacologic response. Am J Cardiol. 1979; 44(2):298-302. DOI: 10.1016/0002-9149(79)90320-5. View

Al-Ghamdi S, Al-Fayyadh M, Hamilton R . Potential new indication for ivabradine: treatment of a patient with congenital junctional ectopic tachycardia. J Cardiovasc Electrophysiol. 2013; 24(7):822-4. DOI: 10.1111/jce.12081. View

Dieks J, Klehs S, Muller M, Paul T, Krause U . Adjunctive ivabradine in combination with amiodarone: A novel therapy for pediatric congenital junctional ectopic tachycardia. Heart Rhythm. 2016; 13(6):1297-302. DOI: 10.1016/j.hrthm.2016.03.015. View

Swedberg K, Komajda M, Bohm M, Borer J, Ford I, Dubost-Brama A . Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010; 376(9744):875-85. DOI: 10.1016/S0140-6736(10)61198-1. View

Janson C, Tan R, Iyer V, Vogel R, Vetter V, Shah M . Ivabradine for treatment of tachyarrhythmias in children and young adults. HeartRhythm Case Rep. 2019; 5(6):333-337. PMC: 6587055. DOI: 10.1016/j.hrcr.2019.03.007. View

Kearns G . Impact of developmental pharmacology on pediatric study design: overcoming the challenges. J Allergy Clin Immunol. 2000; 106(3 Suppl):S128-38. DOI: 10.1067/mai.2000.109419. View

Mildh L, Hiippala A, Rautiainen P, Pettila V, Sairanen H, Happonen J . Junctional ectopic tachycardia after surgery for congenital heart disease: incidence, risk factors and outcome. Eur J Cardiothorac Surg. 2010; 39(1):75-80. DOI: 10.1016/j.ejcts.2010.04.002. View

Ergul Y, Ozturk E, Ozgur S, Ozyurt A, Cilsal E, Guzeltas A . Ivabradine is an effective antiarrhythmic therapy for congenital junctional ectopic tachycardia-induced cardiomyopathy during infancy: Case studies. Pacing Clin Electrophysiol. 2018; 41(10):1372-1377. DOI: 10.1111/pace.13402. View

10.

Villain E, Vetter V, Garcia J, Herre J, Cifarelli A, Garson Jr A . Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study. Circulation. 1990; 81(5):1544-9. DOI: 10.1161/01.cir.81.5.1544. View

11.

DiFrancesco D, Camm J . Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs. 2004; 64(16):1757-65. DOI: 10.2165/00003495-200464160-00003. View

12.

Collins K, Van Hare G, Kertesz N, Law I, Bar-Cohen Y, Dubin A . Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies. J Am Coll Cardiol. 2009; 53(8):690-7. DOI: 10.1016/j.jacc.2008.11.019. View

13.

Bonnet D, Berger F, Jokinen E, Kantor P, Daubeney P . Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure. J Am Coll Cardiol. 2017; 70(10):1262-1272. DOI: 10.1016/j.jacc.2017.07.725. View